BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9301196)

  • 1. Chromosome 22q allelic losses at microsatellite loci in human astrocytic tumors.
    Muhammad AK; Yoshimine T; Maruno M; Tokiyoshi K; Takemoto O; Hayakawa T
    Neurol Med Chir (Tokyo); 1997 Aug; 37(8):606-10; discussion 611. PubMed ID: 9301196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity of microsatellite loci on chromosome 9p in astrocytic tumors and its prognostic implications.
    Maruno M; Yoshimine T; Muhammad AK; Tokiyoshi K; Hayakawa T
    J Neurooncol; 1996 Oct; 30(1):19-24. PubMed ID: 8864999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade.
    Ino Y; Silver JS; Blazejewski L; Nishikawa R; Matsutani M; von Deimling A; Louis DN
    J Neuropathol Exp Neurol; 1999 Aug; 58(8):881-5. PubMed ID: 10446812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.
    Nakamura M; Ishida E; Shimada K; Kishi M; Nakase H; Sakaki T; Konishi N
    Lab Invest; 2005 Feb; 85(2):165-75. PubMed ID: 15592495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
    Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
    Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 17 allelic loss in astrocytic tumors and its clinico-pathologic implications.
    Muhammad AK; Yoshimine T; Maruno M; Tokiyoshi K; Takemoto O; Ninomiya H; Hayakawa T
    Clin Neuropathol; 1997; 16(4):220-6. PubMed ID: 9266149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF; Miller DC; Koslow M; Newcomb EW
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
    Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
    Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
    Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal aberrations detected by comparative genomic hybridization (CGH) in human astrocytic tumors.
    Maruno M; Yoshimine T; Muhammad AK; Ninomiya H; Kato A; Hayakawa T
    Cancer Lett; 1999 Jan; 135(1):61-6. PubMed ID: 10077222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma.
    Hartmann C; Nümann A; Mueller W; Holtkamp N; Simon M; von Deimling A
    Int J Cancer; 2004 Mar; 108(6):839-44. PubMed ID: 14712485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progression-associated gene regions in astrocytomas: a candidate locus on chromosome 19q].
    von Deimling A; Albrecht S; Wiestler OD
    Verh Dtsch Ges Pathol; 1994; 78():423-6. PubMed ID: 7534013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic sub-types of human malignant astrocytoma correlate with survival.
    Leenstra S; Oskam NT; Bijleveld EH; Bosch DA; Troost D; Hulsebos TJ
    Int J Cancer; 1998 Apr; 79(2):159-65. PubMed ID: 9583731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
    von Deimling A; Bender B; Jahnke R; Waha A; Kraus J; Albrecht S; Wellenreuther R; Fassbender F; Nagel J; Menon AG
    Cancer Res; 1994 Mar; 54(6):1397-401. PubMed ID: 8137236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours.
    Miyakawa A; Ichimura K; Schmidt EE; Varmeh-Ziaie S; Collins VP
    Br J Cancer; 2000 Feb; 82(3):543-9. PubMed ID: 10682663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity on the short arm of chromosome 17 in human astrocytomas.
    Wu JK; Darras BT
    Neurol Res; 1992 Mar; 14(1):39-44. PubMed ID: 1351257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of genomic abnormalities in human gliomas.
    Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Cancer Genet Cytogenet; 1994 Apr; 73(2):122-9. PubMed ID: 8174086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis.
    Seng TJ; Ichimura K; Liu L; Tingby O; Pearson DM; Collins VP
    Genes Chromosomes Cancer; 2005 Jun; 43(2):181-93. PubMed ID: 15770670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.